World Journal of Pediatrics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2024-10-02 493473315 来自安徽省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2024-08-12 14891788m58(暂无昵称) 来自云南省

目前更正后IF：3.6

63 0

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2024-03-13 ms4000000361701675 来自广西

投稿命中率:50.0
经验分享：6-8个月接收

90 0

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2024-02-26 ms4000000361701675 来自广西

结合心理相关

126 0

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2023-09-21 科研小帮来自广西

百世登的审稿2-3个月，要伦理证明

151 0

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2022-04-19 ms2000000125490281

投稿命中率:25.0
偏重的研究方向：Pediatrics
经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！

251 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2023-06-01 ms7000000487939564 来自广西

偏重的研究方向：神经系统肿瘤
经验分享：审稿速度2.0

152 0

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2022-11-23 ms4000001383111018

审稿速度:2.0
经验分享：8.16投稿
8.17send back to anthor
8.18分配编辑
8.21分配review
8.22 under review
10.10大修意见到了
10.19返回去
11.18接到小修：确认信息
11.21返回去
11.23接到接收通知
祝大家好运啦！

208 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2022-07-17 Z1998

三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。

222 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228832, encodeId=22a8222883283, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志感觉文章要求很高的啊，去年投了两篇自认为还不错的都直接拒了，今年怎么分数拉胯成这样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98b24794178, createdName=493473315, createdTime=Wed Oct 02 00:30:28 CST 2024, time=2024-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219670, encodeId=356722196e046, content=目前更正后IF：3.6, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13d65313470, createdName=14891788m58(暂无昵称), createdTime=Mon Aug 12 09:05:27 CST 2024, time=2024-08-12, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2192988, encodeId=8c17219298844, content=投稿命中率:50.0 经验分享：6-8个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:43:44 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189443, encodeId=0f92218944360, content=结合心理相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Mon Feb 26 12:18:22 CST 2024, time=2024-02-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158857, encodeId=9ea0215885e06, content=百世登的审稿2-3个月，要伦理证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Sep 21 09:38:50 CST 2023, time=2023-09-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1212482, encodeId=88ab1212482f3, content=投稿命中率:25.0 偏重的研究方向：Pediatrics 经验分享：2021年12月28投的review。2022年2月28号给的返修意见，大修。3月17日返修回去。4月18日收到accept。杂志的编辑非常认真负责，期待期刊越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Apr 19 12:21:56 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140298, encodeId=64ce21402982a, content=偏重的研究方向：神经系统肿瘤 经验分享：审稿速度2.0, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:11:47 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2102154, encodeId=1a74210215478, content=审稿速度:2.0 经验分享：8.16投稿 8.17send back to anthor 8.18分配编辑 8.21分配review 8.22 under review 10.10大修意见到了 10.19返回去 11.18接到小修：确认信息 11.21返回去 11.23接到接收通知 祝大家好运啦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facc5648697, createdName=ms4000001383111018, createdTime=Wed Nov 23 11:01:42 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233009, encodeId=01f0123300962, content=三月投，大修一次，小修一次，七月接收，审稿人和编辑很nice，意见很温和。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0d18108962, createdName=Z1998, createdTime=Sun Jul 17 17:25:00 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219127, encodeId=ceed121912e1f, content=审稿速度:1.0 经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ee15287055, createdName=14855e81m01(暂无昵称), createdTime=Thu May 12 16:51:28 CST 2022, time=2022-05-12, status=1, ipAttribution=)]

2022-05-12 14855e81m01(暂无昵称)

审稿速度:1.0
经验分享：审稿速度比较快，1个月给出初审意见，上传完返修稿，等消息中……

231 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务